HIBBS KATHY L — SEC Form 4 filings
SEC reporting owner CIK 1267487. 20 Form 4 filings on record with FilingPulse; latest filed 2026-09-10.
Transaction summary — filings shown
Covers all 20 filings on record, filed 2024-01-09 to 2026-09-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 12 legs across 12 filings — 366,943 shares, $344,004 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 31.
- Largest priced transaction: sale of 6,250 shares @ $8.68 ($54,233) in SOPHiA GENETICS SA, filed 2026-08-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| 23andMe Holding Co. (ME) | Chief Administrative Officer | 11 | — | 9 legs · 346,935 sh · $203,917 | 20 |
| SOPHiA GENETICS SA (SOPH) | Director | 4 | — | 3 legs · 20,008 sh · $140,087 | 2 |
| STANDARD BIOTOOLS INC. (LAB) | Director | 4 | — | — | 8 |
| SomaLogic, Inc. (SLGC) | Director | 1 | — | — | 1 |
Form 4 filings — HIBBS KATHY L
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-10 | 4 | SOPHiA GENETICS SA (SOPH) | Sale (S): 6,250 @ $8.13 | EDGAR |
| 2026-08-26 | 4 | SOPHiA GENETICS SA (SOPH) | Sale (S): 6,250 @ $8.68 | EDGAR |
| 2026-06-23 | 4 | STANDARD BIOTOOLS INC. (LAB) | Grant/award (A): 99,116 @ $0 · Grant/award (A): 175,923 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | SOPHiA GENETICS SA (SOPH) | Grant/award (A): 19,724 @ $5.46 · Grant/award (A): 28,818 (derivative) @ $5.46 | EDGAR |
| 2026-05-13 | 4 | SOPHiA GENETICS SA (SOPH) | Sale (S): 7,508 @ $4.67 | EDGAR |
| 2025-06-24 | 4 | STANDARD BIOTOOLS INC. (LAB) | Grant/award (A): 94,592 @ $0 · Grant/award (A): 125,660 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | STANDARD BIOTOOLS INC. (LAB) | Grant/award (A): 43,128 @ $0 · Grant/award (A): 72,213 (derivative) @ $0 | EDGAR |
| 2024-05-21 | 4 | 23andMe Holding Co. (ME) | Tax withholding (F): 35,282 @ $0.55 | EDGAR |
| 2024-05-06 | 4 | 23andMe Holding Co. (ME) | Option exercise (M): 38,551 @ $0.42 · Sale (S): 38,551 @ $0.49 · Option exercise (M): 38,551 (derivative) @ $0 | EDGAR |
| 2024-04-19 | 4 | 23andMe Holding Co. (ME) | Option exercise (M): 38,548 @ $0.42 · Sale (S): 38,548 @ $0.47 · Option exercise (M): 38,548 (derivative) @ $0 | EDGAR |
| 2024-04-05 | 4 | 23andMe Holding Co. (ME) | Option exercise (M): 38,548 @ $0.42 · Sale (S): 38,548 @ $0.50 · Option exercise (M): 38,548 (derivative) @ $0 | EDGAR |
| 2024-03-22 | 4 | 23andMe Holding Co. (ME) | Option exercise (M): 38,548 @ $0.42 · Sale (S): 38,548 @ $0.46 · Option exercise (M): 38,548 (derivative) @ $0 | EDGAR |
| 2024-03-11 | 4 | 23andMe Holding Co. (ME) | Option exercise (M): 38,548 @ $0.42 · Sale (S): 38,548 @ $0.53 · Option exercise (M): 38,548 (derivative) @ $0 | EDGAR |
| 2024-02-23 | 4 | 23andMe Holding Co. (ME) | Option exercise (M): 38,548 @ $0.42 · Sale (S): 38,548 @ $0.61 · Option exercise (M): 38,548 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | 23andMe Holding Co. (ME) | Tax withholding (F): 40,522 @ $0.72 | EDGAR |
| 2024-02-16 | 4 | 23andMe Holding Co. (ME) | Option exercise (M): 38,548 @ $0.42 · Sale (S): 38,548 @ $0.78 · Option exercise (M): 38,548 (derivative) @ $0 | EDGAR |
| 2024-01-26 | 4 | 23andMe Holding Co. (ME) | Option exercise (M): 38,548 @ $0.42 · Sale (S): 38,548 @ $0.73 · Option exercise (M): 38,548 (derivative) @ $0 | EDGAR |
| 2024-01-12 | 4 | 23andMe Holding Co. (ME) | Option exercise (M): 38,548 @ $0.42 · Sale (S): 38,548 @ $0.72 · Option exercise (M): 38,548 (derivative) @ $0 | EDGAR |
| 2024-01-09 | 4 | STANDARD BIOTOOLS INC. (LAB) | Grant/award (A): 79,412 @ $0 · Grant/award (A): 205,794 (derivative) | EDGAR |
| 2024-01-09 | 4 | SomaLogic, Inc. (SLGC) | Disposition to issuer (D): 185,400 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1267487 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →